Published in Strahlenther Onkol on December 01, 2009
Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy. J Contemp Brachytherapy (2014) 0.91
Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology Group. Pediatr Blood Cancer (2012) 0.83
Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery. Strahlenther Onkol (2011) 0.79
Intensity modulated perioperative HDR brachytherapy for recurrent and/or advanced head and neck metastases. Eur Arch Otorhinolaryngol (2015) 0.78
Quality control of chemically damaged RNA. Cell Mol Life Sci (2016) 0.78
Iodine-125 orbital brachytherapy with a prosthetic implant in situ. Strahlenther Onkol (2011) 0.77
High-dose-rate brachytherapy of rhabdomyosarcoma limited to the external auditory canal. Brachytherapy (2016) 0.75
Orbital rhabdomyosarcomas: A review. Saudi J Ophthalmol (2013) 0.75
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys (1995) 15.12
Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol (2001) 5.46
The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol (1995) 5.36
The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2005) 2.80
Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG. Int J Radiat Oncol Biol Phys (2001) 2.44
Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. J Clin Oncol (2006) 2.37
Clinical spectrum of primary ophthalmic rhabdomyosarcoma. Ophthalmology (2001) 1.89
Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys (2005) 1.82
Locoregional failure analysis in head-and-neck cancer patients treated with IMRT. Strahlenther Onkol (2007) 1.71
Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. Int J Radiat Oncol Biol Phys (2004) 1.42
Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study. J Clin Oncol (1994) 1.40
The impact of IMRT and proton radiotherapy on secondary cancer incidence. Strahlenther Onkol (2006) 1.36
Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol (1993) 1.35
Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment--results of an international workshop. J Clin Oncol (2001) 1.30
Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys (2005) 1.28
Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys (2000) 1.27
Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer (1998) 1.17
Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991. Med Pediatr Oncol (2000) 1.04
Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys (2008) 1.02
Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses. Strahlenther Onkol (2007) 1.01
Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma. BMC Cancer (2007) 1.00
Orbital rhabdomyosarcoma. Cancer Control (2004) 1.00
Late effects of therapy in orbital rhabdomyosarcoma in children. A report from the Intergroup Rhabdomyosarcoma Study. Cancer (1986) 0.97
The challenging role of radiation therapy for very young children with rhabdomyosarcoma. Int J Radiat Oncol Biol Phys (2006) 0.95
Spot-scanning proton therapy for malignant soft tissue tumors in childhood: First experiences at the Paul Scherrer Institute. Int J Radiat Oncol Biol Phys (2006) 0.94
Multidisciplinary management of refractory orbital rhabdomyosarcoma. Ophthalmology (1997) 0.94
Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams. Int J Radiat Oncol Biol Phys (2000) 0.92
Measured peripheral dose in pediatric radiation therapy: a comparison of intensity-modulated and conformal techniques. Radiother Oncol (2007) 0.90
[Therapy-associated late effects after irradiation of malignant diseases in childhood and adolescence. Feasibility analyses of a prospective multicenter register study]. Strahlenther Onkol (2006) 0.88
Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors. Int J Radiat Oncol Biol Phys (2005) 0.87
Radiation therapy for rhabdomyosarcoma: local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II. Int J Radiat Oncol Biol Phys (1997) 0.87
Fractionated, three-dimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. Int J Radiat Oncol Biol Phys (2000) 0.87
The AMORE protocol for advanced-stage and recurrent nonorbital rhabdomyosarcoma in the head-and-neck region of children: a radiation oncology view. Int J Radiat Oncol Biol Phys (2009) 0.87
A novel local treatment strategy for advanced stage head and neck rhabdomyosarcomas in children: results of the AMORE protocol. Eur J Cancer (2003) 0.85
Surgical lessons from the Intergroup Rhabdomyosarcoma Study. Natl Cancer Inst Monogr (1981) 0.84
Brachytherapy in orbital tumors. Ophthalmology (1997) 0.83
Radiotherapy for orbital lymphoma : outcome and late effects. Strahlenther Onkol (2007) 0.83
Preliminary report of pulsed dose rate brachytherapy in head-and-neck cancer. Strahlenther Onkol (2007) 0.82
The AMORE protocol as salvage treatment for non-orbital head and neck rhabdomyosarcoma in children. Eur J Surg Oncol (2004) 0.79
Radiation late effects in children treated for orbital rhabdomyosarcoma. Radiother Oncol (1999) 0.79
Implant brachytherapy: a novel treatment for recurrent orbital rhabdomyosarcoma. J AAPOS (1997) 0.79
AMORE protocol in pediatric head and neck rhabdomyosarcoma: descriptive analysis of failure patterns. Head Neck (2005) 0.78
Feasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced/recurrent malignancies involving the skull base. Strahlenther Onkol (2005) 0.76
Eye preservation brachytherapy for orbital and adjacent tumors: preliminary results. Front Radiat Ther Oncol (1997) 0.75
An adjuvant afterloading brachytherapy device for use after orbital exenteration in patients with orbital malignancies. Ger J Ophthalmol (1996) 0.75
[Soft tissue sarcoma in children and adolescents: experiences of the cooperative Soft Tissue Sarcoma Group Studies (CWS-81 - 96)]. Handchir Mikrochir Plast Chir (2004) 0.75
Visual acuity after radiation for orbital rhabdomyosarcoma. Am J Ophthalmol (1994) 0.75
[Rhabdomyosarcoma of the orbits in childhood]. Ophthalmologe (1997) 0.75
Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95. J Clin Oncol (2013) 2.98
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet (2012) 2.07
Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. Radiother Oncol (2006) 1.60
GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol (2009) 1.60
Neurocutaneous melanosis: a fatal disease in early childhood. J Clin Oncol (2009) 1.53
Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups. Cancer (2008) 1.28
Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group. J Clin Oncol (2005) 1.21
t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood (2007) 1.10
Management of tectal glioma in childhood. Pediatr Neurol (2005) 1.10
Camptocormia in idiopathic Parkinson's disease: a focal myopathy of the paravertebral muscles. Mov Disord (2010) 1.04
Mesoblastic nephroma--a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH). Cancer (2006) 1.03
A new method of cornea modulation with excimer laser for simultaneous correction of presbyopia and ametropia. Graefes Arch Clin Exp Ophthalmol (2012) 1.00
Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols. Genes Chromosomes Cancer (2014) 0.99
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood (2014) 0.98
Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Cancer Res (2006) 0.96
Acute lymphoblastic leukemia and Klinefelter syndrome in children: two cases and review of the literature. Pediatr Hematol Oncol (2004) 0.95
Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial. J Cancer Res Clin Oncol (2007) 0.94
Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia. Br J Haematol (2005) 0.93
Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia. Haematologica (2006) 0.93
Characterization and expression of CT45 in Hodgkin's lymphoma. Clin Cancer Res (2006) 0.92
Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study. Radiother Oncol (2013) 0.91
Diagnosis and management of cerebral salt wasting (CSW) in children: the role of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP). Childs Nerv Syst (2006) 0.91
Radiation caries--radiogenic destruction of dental collagen. Oral Oncol (2005) 0.90
Comparison of CT- and radiograph-based post-implant dosimetry for transperineal 125I prostate brachytherapy using single seeds and a commercial treatment-planning software. Strahlenther Onkol (2006) 0.88
Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer. Radiother Oncol (2006) 0.87
Extensive aneurysmal bone cyst of the mandible. J Craniofac Surg (2011) 0.86
The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group. Haematologica (2007) 0.86
Primary intracranial soft tissue sarcoma in children and adolescents: a cooperative analysis of the European CWS and HIT study groups. J Neurooncol (2012) 0.85
Feasibility and preliminary outcome of salvage combined HDR brachytherapy and external beam radiotherapy (EBRT) for local recurrences after radical prostatectomy. Brachytherapy (2005) 0.84
Validity and repeatability of the Aladdin ocular biometer. Br J Ophthalmol (2013) 0.84
Chronic interstitial lung disease with lung fibrosis in a girl: uncommon sequelae of Epstein-Barr virus infection. Pediatr Pulmonol (2003) 0.84
Proliferation rate and outcome in children with T-cell rich B-cell lymphoma: a clinicopathologic study from the NHL-BFM-study group. Leuk Lymphoma (2005) 0.83
Potentially accommodating 1CU intraocular lens: 1-year results in 553 eyes and literature review. J Refract Surg (2007) 0.81
Impact to the head increases cochlear implant reimplantation rate in children. Auris Nasus Larynx (2005) 0.81
Chronic subdural hemorrhage into a giant arachnoidal cyst (Galassi classification type III). J Comput Assist Tomogr (2002) 0.81
Three-dimensional reconstruction of seed implants by randomized rounding and visual evaluation. Med Phys (2007) 0.80
Laserinterferometric measurements of accommodative changes in the position of an optic-shift intraocular lens. J Refract Surg (2009) 0.79
Mucosa-associated lymphoid tissue lymphoma in the conjunctiva of a child. Virchows Arch (2004) 0.79
Synchronous detection of a pulmonary papillary adenoma and lung metastases in a patient with osteosarcoma in relapse. Med Pediatr Oncol (2002) 0.79
Imaging of implant needles for real-time HDR-brachytherapy prostate treatment using biplane ultrasound transducers. Med Phys (2009) 0.79
Phantom investigations on CT seed imaging for interstitial brachytherapy. Radiother Oncol (2007) 0.79
Interferon alpha 2b treatment in an eleven-year-old boy with disseminated lymphangiomatosis. Pediatr Blood Cancer (2007) 0.79
Aspirin sensitivity and chronic rhinosinusitis with polyps: a fatal combination. J Allergy (Cairo) (2012) 0.79
The design and testing of a solid phantom for the verification of a commercial 3D seed reconstruction algorithm. Radiother Oncol (2004) 0.78
Neuroblastoma stage 4S with 123I-MIBG-positive bone marrow involvement. Pediatr Blood Cancer (2006) 0.78
Health-related quality of life measurement in long-term survivors and outcome following radical radiotherapy for localized prostate cancer. Strahlenther Onkol (2004) 0.77
Separation of beta2-transferrin by denaturing gel electrophoresis to detect cerebrospinal fluid in ear and nasal fluids. Clin Chem (2005) 0.77
A 10-year-old girl with bifocal synovial sarcoma. Lancet Oncol (2006) 0.77
Imatinib cessation in children and adolescents with chronic myeloid leukemia in chronic phase. Pediatr Blood Cancer (2013) 0.76
High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer. Strahlenther Onkol (2006) 0.76
Feasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced/recurrent malignancies involving the skull base. Strahlenther Onkol (2005) 0.76
Partial-breast irradiation or whole-breast radiotherapy for early breast cancer: a meta-analysis of randomized trials. Strahlenther Onkol (2010) 0.76
Rapid recovery of motor and cognitive functions after resection of a right frontal lobe meningioma in a child. Childs Nerv Syst (2009) 0.76
Allogeneic transplantation for children and adolescents with Hodgkin lymphoma. Blood (2009) 0.75
Proliferation characteristics in pediatric Hodgkin's lymphoma point to a cell cycle arrest in the G(1) phase. Mod Pathol (2005) 0.75
Reply to A.S. Reese. J Clin Oncol (2013) 0.75
A dosimetric analysis of interstitial intensity modulated implants for pelvic recurrences, base of tongue and orbita tumors with specific references to the ICRU-58. Radiother Oncol (2006) 0.75
A rare desmoid tumor of the shoulder--excision, implantation of brachytherapy applicators and wound closure by pedicle musculus latissimus dorsi flap. Ger Med Sci (2011) 0.75
Co-operative bidding of SMEs in health care sector. Stud Health Technol Inform (2002) 0.75
Rock 'n' roll phacoemulsification technique: noncracking and nonchopping approach. J Cataract Refract Surg (2013) 0.75
ABO-mismatched marrow transplantation: removal of mismatched donor red blood cells by "washing" with recipient's matched red blood cells in a closed system. Transfusion (2005) 0.75
[New irradiation method in breast cancer. What is the value of brachytherapy? (interview by Erik Heintz)]. MMW Fortschr Med (2003) 0.75